drugset / Trial / NCT00006682
Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of vinorelbine combined with docetaxel in treating women who have metastatic breast cancer.
Timeline
- Start
- 2000-02
- Primary completion
- 2002-01-22
- Completion
- 2002-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 70 mg/m2 | Intravenous |
| Subject | Vinorelbine | Small molecule | 20 mg/m2 | Intravenous |